title: Polymorphism in the PAI-1 (SERPINE1) gene and the risk of osteonecrosis in children with acute lymphoblastic leukemia.
authors: Jonathan
authors: J
authors: Bond
authors: Stuart
authors: S
authors: Adams
authors: Susan
authors: S
authors: Richards
authors: Ajay
authors: A
authors: Vora
authors: Christopher
authors: C
authors: Mitchell
authors: Nicholas
authors: N
authors: Goulden
mesh_terms: D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D001215:Asparaginase / Q000008:administration & dosage; D002648:Child; D002986:Clinical Trials as Topic / Q000706:statistics & numerical data; D003907:Dexamethasone / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D005787:Gene Frequency; D020022:Genetic Predisposition to Disease; D006801:Humans; D008297:Male; D015337:Multicenter Studies as Topic / Q000706:statistics & numerical data; D010020:Osteonecrosis / Q000139:chemically induced / Q000235:genetics*; D017395:Plasminogen Activator Inhibitor 1 / Q000235:genetics*; D011092:Polyethylene Glycols / Q000008:administration & dosage; D020641:Polymorphism, Single Nucleotide; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000150:complications* / Q000188:drug therapy; D011239:Prednisolone / Q000008:administration & dosage / Q000009:adverse effects; D012307:Risk Factors
chemical_list: D017395:Plasminogen Activator Inhibitor 1; C051321:SERPINE1 protein, human; D011092:Polyethylene Glycols; C042705:pegaspargase; D003907:Dexamethasone; D011239:Prednisolone; D001215:Asparaginase